
AI for inclusive healthcare
Location: Paris, France
Focus: AI-driven platform to optimize drug derivatives and clinical trials for CNS disorders
Founders: Iris Maréchal (CEO) and Chloé Geoffroy (CTO)
Employees: ~7
Known investors: Salica, Eurazeo, Bpifrance
Precision medicine for CNS disorders; drug optimization and clinical trial responder identification.
Health technology / Precision medicine
6410000.00 USD
Other investors reported include Eurazeo and Bpifrance; Crunchbase lists multiple (~8) investors.
“Salica, Eurazeo, Bpifrance”